PG
ISEE

PEAK6 Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

PEAK6 Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-15,800
Closed -$806K – 4833
2016
Q2 		$806K Buy
+15,800
New +$785K 0.01% 1977

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PEAK6 Group's ISEE Position: Q3 2016 in Review

PEAK6 Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2016, closing a stake of 5,716 shares — an estimated $292K sold.

PEAK6 Group first reported a position in ISEE in Q2 2016 and held it in 1 quarter. The position peaked at $292K in Q2 2016. 191 funds tracked by Wall St. Rank hold ISEE as of Q3 2016.

  • PEAK6 Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • PEAK6 Group sold 5,716 IVERIC bio, Inc. Common Stock shares in Q3 2016, an estimated $292K.
  • PEAK6 Group first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 1 quarter.
  • PEAK6 Group's IVERIC bio, Inc. Common Stock position peaked at $292K in Q2 2016.
  • 191 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2016.

Based on PEAK6 Group's 13F filing for Q3 2016, filed 14 Nov 2016.